Last reviewed · How we verify
pegylated Somatropin
At a glance
| Generic name | pegylated Somatropin |
|---|---|
| Also known as | PEG-rhGH,PEG-growth hormone,PEG-Somatropin, PEG somatropin, PEG GH, pharmacokinetics, growth hormone deficiency |
| Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
- A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature (PHASE2)
- Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature (PHASE2)
- A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome
- Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children (PHASE2, PHASE3)
- A Trial of YPEG-rhGH in Children With Short Stature (PHASE2)
- A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency (PHASE3)
- A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |